[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

November 2017 - July 1883

Decade

Year

Issue

July 4, 2017, Vol 318, No. 1, Pages 7-102

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2017;318(1):7-9. doi:10.1001/jama.2016.13201
Viewpoint

Financing and Distribution of Pharmaceuticals in the United States

Abstract Full Text
free access
JAMA. 2017;318(1):21-22. doi:10.1001/jama.2017.5607

This Viewpoint identifies stakeholders in the financing and distribution of pharmaceuticals in the United States and describes their flow from manufacturers through distributors, managers, and retailers to patients.

Human Insulin for Type 2 DiabetesAn Effective, Less-Expensive Option

Abstract Full Text
JAMA. 2017;318(1):23-24. doi:10.1001/jama.2017.6939

This Viewpoint suggests that clinicians prescribe human insulin products as a more-affordable option over insulin analogues and explains dosing options.

Can Personalized Care Planning Improve Primary Care?

Abstract Full Text
JAMA. 2017;318(1):25-26. doi:10.1001/jama.2017.6953

This Viewpoint proposes that integration of patient goals, optimization of chronic disease management, and central record-keeping are essential if personalized care planning is to improve primary care and patient outcomes rather than simply burden primary care practices.

No Shortcuts on the Long Road to Evidence-Based Genomic Medicine

Abstract Full Text
JAMA. 2017;318(1):27-28. doi:10.1001/jama.2017.6315

This Viewpoint discusses the 2017 National Academies of Sciences, Engineering, and Medicine (NASEM) report on improving the system of evaluation of genetic testing so that implementation of genomic medicine in clinical settings can be evidence-based.

A Piece of My Mind

No Perfect Choice

Abstract Full Text
JAMA. 2017;318(1):29-30. doi:10.1001/jama.2017.5523
Editorial

Hypoglycemia in DiabetesDoes Insulin Type Matter?

Abstract Full Text
JAMA. 2017;318(1):31-32. doi:10.1001/jama.2017.8075
Original Investigation

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 DiabetesThe SWITCH 1 Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA. 2017;318(1):33-44. doi:10.1001/jama.2017.7115

This crossover nonineriority trial compared the effects of insulin degludec with insulin glargine U100 in reducing on rates of symptomatic hypoglycemic episodes among adult patients with type 1 diabetes.

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 DiabetesThe SWITCH 2 Randomized Clinical Trial

Abstract Full Text
JAMA. 2017;318(1):45-56. doi:10.1001/jama.2017.7117

This randomized crossover clinical trial compares the effects of insulin degludec vs insulin glargine U100 on rates of hypoglycemia in patients with type 2 diabetes mellitus (T2DM).

Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic EncephalopathyA Randomized Clinical Trial

Abstract Full Text
JAMA. 2017;318(1):57-67. doi:10.1001/jama.2017.7218

This randomized 2 × 2 factorial trial compares the effects of hypothermia depth (32.0°C vs 33.5°C) and duration (72 vs 120 hours) on death and disability among infants with moderate or severe hypoxic-ischemic encephalopathy.

Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back PainThe Mint Randomized Clinical Trials

Abstract Full Text
has active quiz
JAMA. 2017;318(1):68-81. doi:10.1001/jama.2017.7918

This report describes findings from 3 randomized clinical trials designed to compare the effects of a standardized exercise program with vs without radiofrequency denervation for treatment of chronic low back pain.

JAMA Insights

Penicillin Allergy Is Not Necessarily Forever

Abstract Full Text
has active quiz has audio
JAMA. 2017;318(1):82-83. doi:10.1001/jama.2017.6510

This JAMA Insights article explains the association between prescribing antibiotics based on patients’ outdated history of penicillin allergy and the risk of increased antimicrobial resistance.

JAMA Clinical Challenge

A Large Adrenal Tumor With Marked 18F-Fluorodeoxyglucose Uptake

Abstract Full Text
JAMA. 2017;318(1):84-85. doi:10.1001/jama.2017.6326

An asymptomatic 56-year-old woman had a nonsecreting heterogeneous adrenal mass with irregular margins and marked 18F-FDG uptake on PET imaging. What would you do next?

From The Medical Letter on Drugs and Therapeutics

Anaphylaxis and Insect Stings and Bites

Abstract Full Text
JAMA. 2017;318(1):86-87. doi:10.1001/jama.2017.6470

This Medical Letter review summarizes management of anaphylaxis and of insect bites and stings, including information about commercially available epinephrine auto-injectors for use by at-risk patients.

Research Letter

Personal Sound Amplification Products vs a Conventional Hearing Aid for Speech Understanding in Noise

Abstract Full Text
JAMA. 2017;318(1):89-90. doi:10.1001/jama.2017.6905

This cross-sectional study compared functional hearing with use of personal sound amplification products vs conventional hearing aid among older adults with mild to moderate hearing loss.

Comment & Response

Osteoporotic Fractures Associated With Dabigatran vs Warfarin

Abstract Full Text
JAMA. 2017;318(1):90-91. doi:10.1001/jama.2017.6908

The Joint Commission and the Opioid Epidemic

Abstract Full Text
JAMA. 2017;318(1):91-92. doi:10.1001/jama.2017.6694

Osteoporotic Fractures Associated With Dabigatran vs Warfarin—Reply

Abstract Full Text
JAMA. 2017;318(1):91. doi:10.1001/jama.2017.6912

Physicians Interrupting Patients

Abstract Full Text
JAMA. 2017;318(1):92-93. doi:10.1001/jama.2017.6485

The Joint Commission and the Opioid Epidemic—Reply

Abstract Full Text
JAMA. 2017;318(1):92. doi:10.1001/jama.2017.6701

Physicians Interrupting Patients

Abstract Full Text
JAMA. 2017;318(1):93. doi:10.1001/jama.2017.6489

Physicians Interrupting Patients

Abstract Full Text
JAMA. 2017;318(1):93-94. doi:10.1001/jama.2017.6493

Physicians Interrupting Patients—Reply

Abstract Full Text
JAMA. 2017;318(1):94-95. doi:10.1001/jama.2017.6497
Medical News & Perspectives

The Hunt Continues for Early Ovarian Cancer Clues

Abstract Full Text
JAMA. 2017;318(1):14-16. doi:10.1001/jama.2017.5545

This Medical News article discusses efforts aimed at developing ovarian cancer screening and prevention strategies.

Bench to Bedside

Bench to Bedside and Back Again May Be Key to Clinical Breakthroughs

Abstract Full Text
JAMA. 2017;318(1):16-17. doi:10.1001/jama.2017.7276
The JAMA Forum

Payment Power to the Patients

Abstract Full Text
free access
JAMA. 2017;318(1):18-19. doi:10.1001/jama.2017.7533
News From the Food and Drug Administration

A First for Giant Cell Arteritis

Abstract Full Text
JAMA. 2017;318(1):20. doi:10.1001/jama.2017.7639

Precision Approach in Cancer Care

Abstract Full Text
JAMA. 2017;318(1):20. doi:10.1001/jama.2017.7641

Expanded Cystic Fibrosis Therapy

Abstract Full Text
JAMA. 2017;318(1):20. doi:10.1001/jama.2017.7643
Poetry and Medicine

First Dissection

Abstract Full Text
JAMA. 2017;318(1):96. doi:10.1001/jama.2017.4125
JAMA Revisited
JAMA Patient Page

Fecal Microbiota Transplantation

Abstract Full Text
free access
JAMA. 2017;318(1):102. doi:10.1001/jama.2017.6466
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2017;318(1):11-12. doi:10.1001/jama.2016.13202
×